A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic acid

Bahar Tunctan, Belma Korkmaz, Ayse Nihal Sari, Meltem Kacan, Demet Unsal, Mehmet Sami Serin, C. Kemal Buharalioglu, Seyhan Sahan-Firat, Wolf Hagen Schunck, John R. Falck, Kafait U. Malik

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Sepsis is a systemic inflammatory response syndrome with a suspected or proven infection caused by any pathogen or a clinical syndrome associated with a high probability of infection. The definition of septic shock includes sepsis-induced hypotension despite adequate fluid resuscitation, along with the presence of organ perfusion abnormalities, and ultimately cell dysfunction. As the most common causes of morbidity and mortality in intensive care units worldwide, the societal and economic costs of sepsis and septic shock are staggering. The molecular pathophysiology of sepsis and septic shock and the complex roles played by cytokines, reactive oxygen and nitrogen species, and eicosanoids remain controversal despite decades of study. The lipid A part of lipopolysaccharide, also known as endotoxin, is the most potent microbial mediator of the pathogenesis of sepsis and septic shock. 20-Hydroxyeicosatetraenoic acid (20-HETE) is a vasoconstrictor ω-hydroxylation product of arachidonic acid that is produced by cytochrome P450 (CYP) enzymes, mainly by CYP4A and CYP4F isoforms. Studies from our laboratory and others have provided substantial evidence that administration of a synthetic analog of 20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, prevents endotoxininduced vascular hyporeactivity, hypotension, and mortality associated with increased formation of inducible nitric oxide synthase-derived nitric oxide (NO) and cyclooxygenase-2-derived vasodilator prostanoids as well as decreased expression and activity of CYP4A1 and 20-HETE production in a rodent model of septic shock. CYP4A-and CYP4F-derived 20- HETE is also a proinflammatory mediator of endotoxin-induced acute systemic inflammation. In this review, we will present an overview of our current understanding of the interactions between prostanoids, NO, and 20-HETE in sepsis, and provide a rationale for the development of synthetic 20-HETE analogs for the treatment of sepsis and septic shock.

Original languageEnglish (US)
Pages (from-to)121-150
Number of pages30
JournalAnti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
Volume11
Issue number2
DOIs
StatePublished - 2012

Fingerprint

Septic Shock
Prostaglandins
Sepsis
Nitric Oxide
Cytochrome P-450 CYP4A
Endotoxins
Cytochrome P-450 Enzyme System
Therapeutics
Controlled Hypotension
Reactive Nitrogen Species
Systemic Inflammatory Response Syndrome
Lipid A
Eicosanoids
Mortality
Vasoconstrictor Agents
Nitric Oxide Synthase Type II
Cyclooxygenase 2
Hydroxylation
Infection
20-hydroxy-5,8,11,14-eicosatetraenoic acid

Keywords

  • 20-HETE
  • COX-2
  • CYP4A
  • iNOS
  • Sepsis
  • Septic shock

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic acid. / Tunctan, Bahar; Korkmaz, Belma; Sari, Ayse Nihal; Kacan, Meltem; Unsal, Demet; Serin, Mehmet Sami; Buharalioglu, C. Kemal; Sahan-Firat, Seyhan; Schunck, Wolf Hagen; Falck, John R.; Malik, Kafait U.

In: Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, Vol. 11, No. 2, 2012, p. 121-150.

Research output: Contribution to journalArticle

Tunctan, Bahar ; Korkmaz, Belma ; Sari, Ayse Nihal ; Kacan, Meltem ; Unsal, Demet ; Serin, Mehmet Sami ; Buharalioglu, C. Kemal ; Sahan-Firat, Seyhan ; Schunck, Wolf Hagen ; Falck, John R. ; Malik, Kafait U. / A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic acid. In: Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry. 2012 ; Vol. 11, No. 2. pp. 121-150.
@article{ce940bb53689432696ad1fdc66762d62,
title = "A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic acid",
abstract = "Sepsis is a systemic inflammatory response syndrome with a suspected or proven infection caused by any pathogen or a clinical syndrome associated with a high probability of infection. The definition of septic shock includes sepsis-induced hypotension despite adequate fluid resuscitation, along with the presence of organ perfusion abnormalities, and ultimately cell dysfunction. As the most common causes of morbidity and mortality in intensive care units worldwide, the societal and economic costs of sepsis and septic shock are staggering. The molecular pathophysiology of sepsis and septic shock and the complex roles played by cytokines, reactive oxygen and nitrogen species, and eicosanoids remain controversal despite decades of study. The lipid A part of lipopolysaccharide, also known as endotoxin, is the most potent microbial mediator of the pathogenesis of sepsis and septic shock. 20-Hydroxyeicosatetraenoic acid (20-HETE) is a vasoconstrictor ω-hydroxylation product of arachidonic acid that is produced by cytochrome P450 (CYP) enzymes, mainly by CYP4A and CYP4F isoforms. Studies from our laboratory and others have provided substantial evidence that administration of a synthetic analog of 20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, prevents endotoxininduced vascular hyporeactivity, hypotension, and mortality associated with increased formation of inducible nitric oxide synthase-derived nitric oxide (NO) and cyclooxygenase-2-derived vasodilator prostanoids as well as decreased expression and activity of CYP4A1 and 20-HETE production in a rodent model of septic shock. CYP4A-and CYP4F-derived 20- HETE is also a proinflammatory mediator of endotoxin-induced acute systemic inflammation. In this review, we will present an overview of our current understanding of the interactions between prostanoids, NO, and 20-HETE in sepsis, and provide a rationale for the development of synthetic 20-HETE analogs for the treatment of sepsis and septic shock.",
keywords = "20-HETE, COX-2, CYP4A, iNOS, Sepsis, Septic shock",
author = "Bahar Tunctan and Belma Korkmaz and Sari, {Ayse Nihal} and Meltem Kacan and Demet Unsal and Serin, {Mehmet Sami} and Buharalioglu, {C. Kemal} and Seyhan Sahan-Firat and Schunck, {Wolf Hagen} and Falck, {John R.} and Malik, {Kafait U.}",
year = "2012",
doi = "10.2174/187152312803305759",
language = "English (US)",
volume = "11",
pages = "121--150",
journal = "Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry",
issn = "1871-5230",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic acid

AU - Tunctan, Bahar

AU - Korkmaz, Belma

AU - Sari, Ayse Nihal

AU - Kacan, Meltem

AU - Unsal, Demet

AU - Serin, Mehmet Sami

AU - Buharalioglu, C. Kemal

AU - Sahan-Firat, Seyhan

AU - Schunck, Wolf Hagen

AU - Falck, John R.

AU - Malik, Kafait U.

PY - 2012

Y1 - 2012

N2 - Sepsis is a systemic inflammatory response syndrome with a suspected or proven infection caused by any pathogen or a clinical syndrome associated with a high probability of infection. The definition of septic shock includes sepsis-induced hypotension despite adequate fluid resuscitation, along with the presence of organ perfusion abnormalities, and ultimately cell dysfunction. As the most common causes of morbidity and mortality in intensive care units worldwide, the societal and economic costs of sepsis and septic shock are staggering. The molecular pathophysiology of sepsis and septic shock and the complex roles played by cytokines, reactive oxygen and nitrogen species, and eicosanoids remain controversal despite decades of study. The lipid A part of lipopolysaccharide, also known as endotoxin, is the most potent microbial mediator of the pathogenesis of sepsis and septic shock. 20-Hydroxyeicosatetraenoic acid (20-HETE) is a vasoconstrictor ω-hydroxylation product of arachidonic acid that is produced by cytochrome P450 (CYP) enzymes, mainly by CYP4A and CYP4F isoforms. Studies from our laboratory and others have provided substantial evidence that administration of a synthetic analog of 20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, prevents endotoxininduced vascular hyporeactivity, hypotension, and mortality associated with increased formation of inducible nitric oxide synthase-derived nitric oxide (NO) and cyclooxygenase-2-derived vasodilator prostanoids as well as decreased expression and activity of CYP4A1 and 20-HETE production in a rodent model of septic shock. CYP4A-and CYP4F-derived 20- HETE is also a proinflammatory mediator of endotoxin-induced acute systemic inflammation. In this review, we will present an overview of our current understanding of the interactions between prostanoids, NO, and 20-HETE in sepsis, and provide a rationale for the development of synthetic 20-HETE analogs for the treatment of sepsis and septic shock.

AB - Sepsis is a systemic inflammatory response syndrome with a suspected or proven infection caused by any pathogen or a clinical syndrome associated with a high probability of infection. The definition of septic shock includes sepsis-induced hypotension despite adequate fluid resuscitation, along with the presence of organ perfusion abnormalities, and ultimately cell dysfunction. As the most common causes of morbidity and mortality in intensive care units worldwide, the societal and economic costs of sepsis and septic shock are staggering. The molecular pathophysiology of sepsis and septic shock and the complex roles played by cytokines, reactive oxygen and nitrogen species, and eicosanoids remain controversal despite decades of study. The lipid A part of lipopolysaccharide, also known as endotoxin, is the most potent microbial mediator of the pathogenesis of sepsis and septic shock. 20-Hydroxyeicosatetraenoic acid (20-HETE) is a vasoconstrictor ω-hydroxylation product of arachidonic acid that is produced by cytochrome P450 (CYP) enzymes, mainly by CYP4A and CYP4F isoforms. Studies from our laboratory and others have provided substantial evidence that administration of a synthetic analog of 20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, prevents endotoxininduced vascular hyporeactivity, hypotension, and mortality associated with increased formation of inducible nitric oxide synthase-derived nitric oxide (NO) and cyclooxygenase-2-derived vasodilator prostanoids as well as decreased expression and activity of CYP4A1 and 20-HETE production in a rodent model of septic shock. CYP4A-and CYP4F-derived 20- HETE is also a proinflammatory mediator of endotoxin-induced acute systemic inflammation. In this review, we will present an overview of our current understanding of the interactions between prostanoids, NO, and 20-HETE in sepsis, and provide a rationale for the development of synthetic 20-HETE analogs for the treatment of sepsis and septic shock.

KW - 20-HETE

KW - COX-2

KW - CYP4A

KW - iNOS

KW - Sepsis

KW - Septic shock

UR - http://www.scopus.com/inward/record.url?scp=84870270905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870270905&partnerID=8YFLogxK

U2 - 10.2174/187152312803305759

DO - 10.2174/187152312803305759

M3 - Article

VL - 11

SP - 121

EP - 150

JO - Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

JF - Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry

SN - 1871-5230

IS - 2

ER -